Mail: info@sterilize.it  – Linkedin: sterilize.it


  • Member Area
  • Registration
  • About us
  • Processes
  • Applications
  • Bookstore
  • Useful Links
  • Contact us
  • About us
  • Processes
  • Applications
  • Bookstore
  • Useful Links
  • Contact us

A history of isolator and containment technology, Part 6: Development of the validation of isolators

Abstract This final section is devoted to the development of various validation methods conforming to GMP when applied to isolators and also a review of the methods in relation to validating the processes used in preparing for aseptic processing and sterility testing. There are brief comments on what the regulators expect. Early aspects Validation, as far […]
  • author: Thorogood Doug
Read More

Current USP Perspectives on Sterilization & Sterility Assurance

Sterilization, Sterility Assurance & Sterility Testing. What’s on the Horizon? Who’s on the MSA Committee? James Akers, Ph.D., AK&A, Chairman  Scott Sutton, Ph.D., Vectech, Vice-Chair  James Agalloco, A&A Ivan Chin, Ph.D., J&J Anthony Cundell, Schering Plough J. Kirby Farrington, Ph.D., Eli Lilly Dennis Guilfoyle, Ph.D., FDA ORA David Hussong, Ph.D., FDA CDER Leonard Mestrandrea, Ph.D., […]
  • author: Agalloco James
Read More

Continued process verification methods in cleaning validation TOC

Abstract An increasing interest in continued process verification has brought to the spread of on-line assay methods in cleaning processes [1]. This paper deals with two different on-line applications: conductivity sampling and the Total Organic Carbon analysis for washing machines. Keywords: moist-heat sterilization, steam sterilization of aqueous solutions, sealed containers, headspace volume, internal pressure, autoclaving, […]
  • author: Ferretti Sara
Read More

Results after a chemical decontamination cycle performed with vaporized H2O2

Abstract This article discusses the challenge of the unexpected growth of a positive biological indicator in a chemical decontamination cycle. Specific features to be considered regarding biological indicators used for the validation of decontamination cycles are presented. Some practical solutions are suggested to avoid the risks related to false positives. Keywords: chemical bio-decontamination, hydrogen peroxide, […]
  • author: Bernuzzi Maria Luisa
Read More

Chemical Surface Bio- Decontamination Applied to Material Transfer into Sterile Enclosures

Presentation outline Material transfer to sterile suite issue and available technologies; Surface bio-decontamination drivers; QbD and risk assessment and mitigation overview; Surface chemical bio-decontamination cycle; Cycle validation approach; The material transfer issue… It is critical to adequately control material (e.g., in-processsupplies, equipment, utensils) as it transfers from lesser to higher classified clean areas to prevent […]
  • author: Mauri Sergio
Read More

ISO 14644 – Revision to Parts 1 and 2

Actions and implications of the changes in the International cleanroom standard. ISO 14644 ISO 14644 International cleanroom standard  Part 1 in 1999 12 part standard Electronics, healthcare, biotechnology, pharmaceuticals Replaced FS 209E in 2001 Accepted by EU GMP in 2003 for classification but not monitoring FDA aseptic filling guide in 2004. ISO 14644 – parts […]
  • author: Sandle Tim
Read More

Aseptic Processing Risk Assessment: The Simplified Akers-Agalloco Method

Abstract This method is an effort to assess risk in aseptic processing. We believe because we have broadened the perspective of risk relative to aseptic processing that if nothing else we have increased awareness that risk can vary substantially in what are perceived by many to be equivalent (and thus equally acceptable) practices and technologies. […]
  • author: Agalloco James and Akers James
Read More

Aseptic Processing – Achieving Sterility by Design

Abstract Informal risk mitigation brought about the technology advances seen in aseptic processing. Confidence in aseptic processing is not derived from monitoring or testing; it is the result of attention to detail in aseptic processing design. With newer technologies the emphasis must shift even farther from monitoring & testing.   Aseptic Processing Definition “Handling sterile […]
  • author: Mascherpa Vittorio
Read More

Risk Analysis for Aseptic Processing: The Akers-Agalloco Method

Abstract Aseptic processing is considered by many in this industry to be among the more difficult activities to execute properly. The number of variables that affect the safety of sterile products manufactured aseptically is substantial. In the design and operation of an aseptic production facility, it is essential that risk to the patient be minimized. […]
  • author: Akers James and Agalloco James
Read More
Search
  • Enter your keyword

  • Processes

  • Applications

  • Author

Recent articles
  • A History of Isolator and Containment Technology, Part 5: Development and use of sterilising agents with associated devices
  • A history of isolator and containment technology Part 4: Transfer devices
  • A history of isolator and containment technology Part 3: Non-flexible film isolators including RABS
  • A history of isolator and containment technology Part 2: Flexible film isolators
  • Importance of risk assessment for aseptic transfer in pharmaceutical compounding
Scroll
Contact

Mail: info@sterilize.it
Linkedin: sterilize.it

Member Area
Accesso
Password persa
Process
  • Aseptic processing
  • Cleaning
  • Chemical bio-decontamination
  • Moist-heat sterilization
  • Sterilization
Application
  • Blood bags
  • Environmental Monitoring
  • Food
  • General
  • Hyaluronic Acid
  • Other applications
  • Package Integrity
  • Pharma – Liquids
  • Pharmaceutical compounding
  • Pre-filled syringes (PFSs)
  • Robotics
  • Sealed containers
  • Validation
Subscribe to newsletter

Subscribe to our newsletter to stay informed about our news and info.

Join here

© Copyright 2020 Sterilize.it. All rights reserved. Privacy Policy e Cookie

Fedegari Autoclavi SpA | Albuzzano - SS 235 Km 8, CAP. 27010 (PV) | REA: PV- 130961 | P.IVA IT00303010185 | PEC: amministrazione@pec.fedegari.com | Capitale Sociale Versato 5.000.000,00 € i.v.